Company: BDRX
Filing Date: 2025-12-08
Form Type: F-1/A
Source: 0001214659-25-017719
Chunk: 167

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-12-08
Form: F-1/A
Chunk 167
---
 as amended, this Registration Statement on Form F-1 has been signed by the following persons in the capacities and on the
date indicated.

| Name and Signature    
 /s/ Stephen Stamp     |     | Title(s)                                                                                  
 Chief Executive Officer, Director,                                                        |     | Date             
 December 8, 2025 |
|:----------------------|:----|:------------------------------------------------------------------------------------------|:----|:-----------------|
| Stephen Stamp         |     | Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer |     |                  |
| *                     |     | Non-Executive Chairman of the Board                                                       |     | December 8, 2025 |
| Stephen Parker        |     |                                                                                           |     |                  |
| *                     |     | Senior Independent Non-Executive Director                                                 |     | December 8, 2025 |
| Simon Turton, Ph.D.   |     |                                                                                           |     |                  |
| *                     |     | Non-Executive Director                                                                    |     | December 8, 2025 |
| Sijmen de Vries, M.D. |     |                                                                                           |     |                  |
| *                     |     | Non-Executive Director                                                                    |     | December 8, 2025 |
| Ann Merchant          
 *By: /s/Stephen Stamp 
 Stephen Stamp         
 Attorney-in-fact      |     |                                                                                           |     |                  |

| II-5 |

<div align='center'>AUTHORIZED REPRESENTATIVE</div>

Pursuant to the requirements
of the Securities Act of 1933, as amended, this Registration Statement on Form F-1 has been signed by the undersigned on this 8th day
of December, 2025.

| By:    | /s/ Donald J. Puglisi                          |
| Name:  | Donald J. Puglisi                              |
| Title: | Authorized Representative in the United States |

| II-6 |

<div align='center'>Exhibit Index</div>

| Exhibit 
 Number  
 3.1     
 4.1     |     | Title                                                                                                                                                                                                                                                                                                                                                                                         
 Articles of Association of Biodexa Pharmaceuticals PLC, adopted on June 11, 2025 (incorporated by reference to Exhibit 1.1 to the Company’s Report on Form 6-K, filed with the SEC on June 13, 2025).                                                                                                                                                                                         
 Description of Securities Registered Under Section 12 of the Exchange Act (incorporated by reference to Exhibit